Topical ocular delivery to laser-induced choroidal neovascularization by dual internalizing RGD and TAT peptide-modified nanoparticles

References

• JianLPanpanYWenXCurrent choroidal neovascularization treatmentOphthalmologica20132302556123949022
   PubMedGoogle Scholar
• GehrsKMAndersonDHJohnsonLVHagemanGSAge-related macular degeneration – emerging pathogenetic and therapeutic conceptsAnn Med200638745047117101537
   PubMed Web of Science ®Google Scholar
• KompellaUBAmriteACPacha RaviRDurazoSANanomedicines for back of the eye drug delivery, gene delivery, and imagingProg Retin Eye Res20133617219823603534
   PubMed Web of Science ®Google Scholar
• MauriceDReview: practical issues in intravitreal drug deliveryJ Ocul Pharmacol Ther200117439340111572470
   PubMedGoogle Scholar
• LimJIWolitzRADowlingAHBloomHRIrvineARSchwartzDMVisual and anatomic outcomes associated with posterior segment complications after ganciclovir implant procedures in patients with AIDS and cytomegalovirus retinitisAm J Ophthalmol1999127328829310088738
   PubMed Web of Science ®Google Scholar
• ShaneTSMartinDFEndopthalmitis-Gancioclovir Implant Study GroupEndophthalmitis after ganciclovir implant in patients with AIDS and cytomegalovirus retinitisAm J Ophthalmol2003136464965414516804
   PubMed Web of Science ®Google Scholar
• JanoriaKGGundaSBodduSHMitraAKNovel approaches to retinal drug deliveryExpert Opin Drug Deliv20074437138817683251
   PubMed Web of Science ®Google Scholar
• SahooSKDilnawazFKrishnakumarSNanotechnology in ocular drug deliveryDrug Discov Today2008133–414415118275912
   PubMed Web of Science ®Google Scholar
• InokuchiYHironakaKFujisawaTPhysicochemical properties affecting retinal drug/coumarin-6 delivery from nanocarrier systems via eyedrop administrationInvest Ophthalmol Vis Sci20105163162317020053972
   PubMed Web of Science ®Google Scholar
• TrabuloSCardosoALManoMDe LimaMCCell-penetrating peptides-mechanisms of cellular uptake and generation of delivery systemsPharmaceuticals (Basel)20103496199327713284
   PubMedGoogle Scholar
• FarkhaniSMValizadehAKaramiHMohammadiSSohrabiNBadrzadehFCell penetrating peptides: efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic moleculesPeptides201457789424795041
   PubMed Web of Science ®Google Scholar
• JohnsonLNCashmanSMKumar-SinghRCell-penetrating peptide for enhanced delivery of nucleic acids and drugs to ocular tissues including retina and corneaMol Ther200816110711417923842
   PubMed Web of Science ®Google Scholar
• LiuCTaiLZhangWWeiGPanWLuWPenetratin, a potentially powerful absorption enhancer for noninvasive intraocular drug deliveryMol Pharm20141141218122724521351
   PubMedGoogle Scholar
• WangYLinHLinSCell-penetrating peptide TAT-mediated delivery of acidic FGF to retina and protection against ischemia-reperfusion injury in ratsJ Cell Mol Med20101471998200519432810
   PubMed Web of Science ®Google Scholar
• LeavesleyDISchwartzMARosenfeldMChereshDAIntegrin beta 1- and beta 3-mediated endothelial cell migration is triggered through distinct signaling mechanismsJ Cell Biol199312111631707681432
   PubMed Web of Science ®Google Scholar
• FriedlanderMTheesfeldCLSugitaMInvolvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseasesProc Natl Acad Sci U S A19969318976497698790405
   PubMed Web of Science ®Google Scholar
• LunaJTobeTMousaSAReillyTMCampochiaroPAAntagonists of integrin alpha v beta 3 inhibit retinal neovascularization in a murine modelLab Invest19967545635738874387
   PubMed Web of Science ®Google Scholar
• SchraaAJKokRJMoorlagHETargeting of RGD-modified proteins to tumor vasculature: a pharmacokinetic and cellular distribution studyInt J Cancer2002102546947512432548
   PubMedGoogle Scholar
• SinghSRGrossniklausHEKangSJEdelhauserHFAmbatiBKKompellaUBIntravenous transferrin, RGD peptide and dual-targeted nanoparticles enhance anti-VEGF intraceptor gene delivery to laser-induced CNVGene Ther200916564565919194480
   PubMed Web of Science ®Google Scholar
• YuKFZhangWQLuoLMThe antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluationInt J Nanomedicine201382473248523885174
   PubMed Web of Science ®Google Scholar
• SoppimathKSAminabhaviTMKulkarniARRudzinskiWEBiodegradable polymeric nanoparticles as drug delivery devicesJ Control Release2001701–212011166403
   PubMed Web of Science ®Google Scholar
• ToropainenERantaVPTalvitieASuhonenPUrttiACulture model of human corneal epithelium for prediction of ocular drug absorptionInvest Ophthalmol Vis Sci200142122942294811687540
   PubMed Web of Science ®Google Scholar
• EdelmanJLCastroMRQuantitative image analysis of laser-induced choroidal neovascularization in ratExp Eye Res200071552353311040088
   PubMed Web of Science ®Google Scholar
• CressmanSDobsonILeeJBTamYYCullisPRSynthesis of a labeled RGD-lipid, its incorporation into liposomal nanoparticles, and their trafficking in cultured endothelial cellsBioconjug Chem20092071404141119534457
   PubMedGoogle Scholar
• KibriaGHatakeyamaHOhgaNHidaKHarashimaHDual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene deliveryJ Control Release2011153214114821447361
   PubMed Web of Science ®Google Scholar
• TorchilinVPRammohanRWeissigVLevchenkoTSTAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitorsProc Natl Acad Sci U S A200198158786879111438707
   PubMed Web of Science ®Google Scholar
• Araki-SasakiKOhashiYSasabeTAn SV40-immortalized human corneal epithelial cell line and its characterizationInvest Ophthalmol Vis Sci19953636146217534282
   PubMed Web of Science ®Google Scholar
• GiannolaLIde CaroVGiandaliaGSiragusaMGCordoneLOcular gelling microspheres: in vitro precorneal retention time and drug permeation through reconstituted corneal epitheliumJ Ocul Pharmacol Ther200824218619618355132
   PubMed Web of Science ®Google Scholar
• ReichlSDohringSBednarzJMuller-GoymannCCHuman cornea construct HCC-an alternative for in vitro permeation studies? A comparison with human donor corneasEur J Pharm Biopharm200560230530815939241
   PubMedGoogle Scholar
• SugaharaKNTeesaluTKarmaliPPTissue-penetrating delivery of compounds and nanoparticles into tumorsCancer Cell200916651052019962669
   PubMed Web of Science ®Google Scholar
• KamizuruHKimuraHYasukawaTTabataYHondaYOguraYMonoclonal antibody-mediated drug targeting to choroidal neovascularization in the ratInvest Ophthalmol Vis Sci200142112664267211581214
   PubMedGoogle Scholar
• LeeEKKimYJKimJYSongHBYuHGMelissa officinalis extract inhibits laser-induced choroidal neovascularization in a rat modelPLoS One2014910e11010925314292
   PubMedGoogle Scholar
• KimuraHYasukawaTTabataYOguraYDrug targeting to choroidal neovascularizationAdv Drug Deliv Rev2001521799111672877
   PubMedGoogle Scholar
• Schmidt-ErfurthUHasanTGragoudasEMichaudNFlotteTJBirngruberRVascular targeting in photodynamic occlusion of subretinal vesselsOphthalmology199410112195319617997334
   PubMed Web of Science ®Google Scholar
• HughesPMOlejnikOChang-LinJEWilsonCGTopical and systemic drug delivery to the posterior segmentsAdv Drug Deliv Rev200557142010203216289435
   PubMed Web of Science ®Google Scholar
• SchopfLRPopovAMEnlowEMTopical ocular drug delivery to the back of the eye by mucus-penetrating particlesTransl Vis Sci Technol20154311
   PubMed Web of Science ®Google Scholar
• AhmedIPattonTFImportance of the noncorneal absorption route in topical ophthalmic drug deliveryInvest Ophthalmol Vis Sci19852645845873884542
   PubMed Web of Science ®Google Scholar
• BloomfieldSEMiyataTDunnMWBueserNStenzelKHRubinALSoluble gentamicin ophthalmic inserts as a drug delivery systemArch Ophthalmol1978965885887655927
   PubMedGoogle Scholar
• AmriteACKompellaUBSize-dependent disposition of nanoparticles and microparticles following subconjunctival administrationJ Pharm Pharmacol200557121555156316354399
   PubMed Web of Science ®Google Scholar
• XuPGullottiETongLIntracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisitedMol Pharm20096119020119035785
   PubMed Web of Science ®Google Scholar
• SunXLiFWangYLiangWCellular uptake and elimination of lipophilic drug delivered by nanocarriersPharmazie2010651073774221105575
   PubMedGoogle Scholar
• LinT-TGaoD-YLiuY-CDevelopment and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosisJ Control Release2016221627026551344
   PubMed Web of Science ®Google Scholar
• PakaGDRamassamyCOptimization of curcumin loaded-PEG-PLGA nanoparticles by GSH functionalization. Investigation of the internalization pathway in neuronal cellsMol Pharm20161419310627744707
   PubMedGoogle Scholar